N/A
N=1,877
Patient-centered Research Into Outcomes Stroke Patients Prefer and Effectiveness Research
Stroke · Ischemic Stroke
Bottom Line
View on ClinicalTrials.gov: NCT02146274 ↗Enrolled (actual)
1,877
Serious AEs
—
Results posted
Jul 2019
Primary outcome: Primary: Depression — .7; .79 units on a scale
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- —
- Age
- Pediatric, Adult, Older Adult
- Sex
- All
- Sponsor
- Duke University
- Primary completion
- Dec 2017
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Depression |
.7; .79 | — |
| SECONDARY Functional Status |
0.77; 0.83 | — |
Summary
PROSPER (Patient-centered Research into Outcomes Stroke patients Prefer and Effectiveness Research) is a three year research project to create a national, sustainable model to improve decision-making and patient-centered stroke outcomes through comparative effectiveness research.
Eligibility Criteria
Inclusion Criteria
- Consistent with GWTG inclusion criteria, patients must be older than 18 and have a primary diagnosis of acute ischemic stroke.
- Ability to give informed consent or the availability of a surrogate who can consent on the patient's behalf.
Exclusion Criteria
- Patients with subarachnoid or intracerebral hemorrhage
- Patients with transient ischemic attack (TIA)
- Patients with expected survival less than 6 months/discharged to hospice
Data sourced from ClinicalTrials.gov (NCT02146274). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.